Prolongation of small bowel allograft survival with a sequential therapy consisting of a synthetic MHC class II peptide and temporarily low-dose cyclosporine A.
Otto C, Gasser M, Waaga-Gasser AM, Rohde AC, Lenhard M, Jost S, Gassel HJ, Ulrichs K, Timmermann W. Prolongation of small bowel allograft survival with a sequential therapy consisting of a synthetic MHC class II peptide and temporarily low-dose cyclosporine A. Hum Immunol. 2002 Oct; 63(10):880-7.